Note: All links within
content go to MayoClinic.com
Diseases and Conditions
Postherpetic neuralgia
From MayoClinic.com
Special to CNN.com Introduction Postherpetic neuralgia (post-her-PET-ic noo-RAL-jah) is a painful condition affecting your nerve fibers and skin. It's a complication of shingles, a second outbreak of the varicella-zoster virus, which initially causes chickenpox. During an initial infection of chickenpox, some of the virus can remain in your system, lying dormant inside nerve cells. Years later, factors such as age, illness, stress or medications can reactivate the virus, causing shingles, or it can also reactivate for no apparent reason. Once reactivated, the virus travels along nerve fibers, causing pain. When the virus reaches your skin, it produces a rash and blisters. A case of shingles (herpes zoster) usually heals within a month. But some people continue to feel pain long after the rash and blisters heal. This pain is known as postherpetic neuralgia. Not everyone who's had a reactivation of the virus develops postherpetic neuralgia. But postherpetic neuralgia is a common complication of shingles in older adults. The greater your age when the virus reactivates, the greater the chance you'll develop postherpetic neuralgia. In most people, the pain of postherpetic neuralgia lessens over time. In the meantime — especially if symptoms are addressed early — treatments for postherpetic neuralgia can ease nerve-related pain. Signs and symptoms The symptoms of postherpetic neuralgia are generally limited to the area of your skin where the shingles outbreak first occurred. They may include:
In rare cases, you might also experience muscle weakness or paralysis — if the nerves involved also control muscle movement. Causes Postherpetic neuralgia results when nerve fibers are damaged during an outbreak of shingles. Damaged fibers aren't able to send messages from your skin to your brain as they normally do. Instead, the messages become confused and exaggerated, causing chronic, often excruciating pain that may persist for months — or even years — in the area where shingles first occurred. This complication of shingles occurs much more frequently in older adults. Less than 10 percent of people younger than 60 develop postherpetic neuralgia after a bout of shingles, while about 40 percent of people older than 60 do. When to seek medical advice See a doctor at the first sign of shingles. Treating shingles early — within three days of developing the rash — and aggressively with oral antiviral drugs may reduce the length and severity of postherpetic neuralgia. If you do develop postherpetic neuralgia, see your doctor right away. Finding an effective treatment to relieve the pain can sometimes be frustrating. You may have to work with your doctor and sometimes other specialists to try a variety of treatments before you find something that helps. Treatment Treatment for postherpetic neuralgia depends on the type of pain you experience. Possible options include:
In some cases, treatment of postherpetic neuralgia brings complete pain relief. But most people still experience some pain, and a few don't receive any relief. Although some people must live with postherpetic neuralgia the rest of their lives, most people can expect the condition to gradually disappear during the first three months. For about 10 percent to 20 percent of people with postherpetic neuralgia, the pain may persist for a year or more. Prevention Although a vaccine to prevent chickenpox is available, its effect on postherpetic neuralgia is unknown. The vaccine — made from a weakened form of the varicella-zoster virus — may keep chickenpox from occurring in nonimmune children and adults, or at least lessen the risk of the chickenpox virus lying dormant in the body and reactivating later as shingles. If shingles could be prevented, postherpetic neuralgia could be completely avoided. If you've already had chickenpox, the vaccine can't prevent shingles because the varicella-zoster virus is already in your body. However, researchers in 2005 reported the results of a 10-year trial of a more potent version of the chickenpox vaccine. In what was called the Shingles Prevention Study, researchers reported that the vaccine reduced the incidence of shingles by about half compared with a placebo. And, in people who developed shingles, the vaccine significantly reduced the severity of the disease and lessened the risk of complications, such as postherpetic neuralgia. The vaccine is awaiting approval from the U.S. Food and Drug Administration. Self-care After talking with your doctor, you may find the following over-the-counter medications ease the pain of postherpetic neuralgia:
June 05, 2006 |